Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Melphalan and TBI with PBSC for Relapsing Multiple Myeloma
NCT00002630Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jun 1993
- Primary completion
- Feb 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of melphalan in multiple myeloma (MM), sponsored by Mayo Clinic. Primary endpoint: Bone marrow reconstitution. Started Jun 1993; status: completed.
02
Drugs
melphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00002630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002630.